Bruker Corp (BRKR) Stock Price, Quote & News

Company Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, inte...

Industry: Medical Devices

Sector: Healthcare

Phone: 978 663 3660

Fax: 978 663 5585

Website: www.bruker.com

Address:

40 Manning Road, Billerica, United States

JarvisFlow Jun. 26 at 6:00 PM

B of A Securities updates rating for Bruker ( $BRKR ) to Buy, target set at 61 → 50.

0 · Reply

Professler Jun. 26 at 3:04 PM

$CYN Excellent trade today. Along with $BRKR . I'm locked and loaded in Bruker for the long term. With only a 6B market cap, this will double by the end of the year.

0 · Reply

DonCorleone77 Jun. 25 at 10:07 PM

$BRKR $ICLR $MEDP NIH directs staff not to end any extra research projects for now, NY Times says A senior official the National Institutes of Health has told agency staff not to cancel any more research projects for the time being in the wake of two court rulings taking umbrage with the cancellation of medical research grants by the Trump administration, the New York Times' Benjamin Mueller reports, citing an internal memo. The directive marks a retreat by the agency, as it has slashed funding for medical research since Trump's return to office by terminating hundreds of awards, the author notes. Shares of Illumina (ILMN), Thermo Fisher (TMO), Avantor (AVTR), and Bruker (BRKR) moved higher following the news while Icon (ICLR) and Medpace (MEDP) were still in the red but curtailed some earlier losses.

0 · Reply

Roberto_Claro Jun. 25 at 9:47 PM

BREAKING NEWS PLAYBOOK TRADES Long: $BRKR. Short: $UNH. Trade Review & Management: BRKR trade was really tricky. I was aware that there was some kind of government event but I did not know what was going on at the time. What conviced me to participate in this name was that other related names (ILMN, TMO) started to spike again so I jumped long. That hesitation (in this time it was justified, I did not get the exact headline from my sources) "cost" me some money because I entered kind of late. Overall nice trade. Regarding UNH, 7/10 DOJ headlines are negative. I bought at first because that was the initial reaction but once 2-min bar low was broken I flipped right away with slightly more size than the short. Realtime Trade Execution: BRKR trade https://vimeo.com/1096402820/a4ee21d50b?ts=0&share=copy | UNH trade https://vimeo.com/1096403212/09d8d60d91?ts=0&share=copy

0 · Reply

JMG2000 Jun. 25 at 7:00 PM

$BRKR watching

0 · Reply

Professler Jun. 10 at 2:40 PM

$BRKR About time this gets some love. There's too much growth potential and excellent technology here to keep it down forever. See you at 60 soon.

0 · Reply

topstockalerts Jun. 10 at 1:55 PM

$BRKR it took off.. 🙌 Stay tuned for more!🍾🍾

0 · Reply

ZacksResearch Jun. 10 at 1:14 PM

$BRKR just announced a strategic acquisition — will it boost the stock? 🤔 📈 Shares have climbed 4.8% since the announcement of acquiring biocrates, a global leader in MS-based metabolite analysis. 🔬 This move strengthens Bruker's multiomics capabilities, key for the future of life sciences. See if BRKR's expansion could power its next growth phase 👉 https://www.zacks.com/commentary/2492104/bruker-stock-set-to-gain-from-acquisition-of-austrias-biocrates?cid=sm-stocktwits-2-2492104-body&ADID=SYND_STOCKTWITS_TWEET_2_2492104_BODY

0 · Reply

ZacksResearch Jun. 10 at 11:08 AM

$BRKR just made a strategic move — here’s why it matters 👀 The biocrates acquisition enhances its MS-based metabolomics platform, a clear signal the company’s doubling down on high-growth diagnostics. Discover why this could lift Bruker’s stock 👉 https://www.zacks.com/stock/news/2492104/bruker-stock-set-to-gain-from-acquisition-of-austrias-biocrates?cid=sm-stocktwits-2-2492104-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2492104_TEASER

0 · Reply

MVL0502 Jun. 3 at 2:48 PM

$BRKR Bruker acquires Austria based biocrates. - Bruker Corporation (NASDAQ:BRKR) on Tuesday announced the acquisition of biocrates life sciences ag, located in Innsbruck, Austria. - Financial terms were not disclosed. - The acquisition of biocrates further enhances Bruker’s MS-based metabolomics solutions. - It also supports Bruker’s (NASDAQ:BRKR) expansion into multiomics solutions, including instruments, reagents, software, and research services.

0 · Reply

Bruker Experiences Growth in Semiconductor Advanced Packaging Market Fueled by AI Demands

Jun 3, 2025, 11:00 AM EDT - 24 days ago

Bruker Applied MS Unveils Strategic Innovations at ASMS 2025, Showcasing Advances in DART Technology for TDM and DoA Analysis and Launching timsMetabo™ for PFAS and Environmental Contaminant Detection

Jun 3, 2025, 7:00 AM EDT - 24 days ago

Bruker Announces Acquisition of biocrates, a Leader in Mass Spectrometry-based Quantitative Metabolomics

Jun 2, 2025, 7:01 AM EDT - 25 days ago

Bruker Launches New timsUltra AIP System with Further Enhanced, Extreme Sensitivity for Single-Cell Proteomics, FNA Biopsy Immunopeptidomics and Metaproteomics

Jun 2, 2025, 7:00 AM EDT - 25 days ago

Bruker Unveils New proteoElute™ nanoLC System and PepSep® Advanced nLC Columns for up to 50% Improved Peptide Sensitivity

May 30, 2025, 4:31 PM EDT - 4 weeks ago

Bruker Corporation to Present at the Jefferies Global Healthcare Conference

May 30, 2025, 8:00 AM EDT - 4 weeks ago

Bruker Launches Revolutionary timsOmniTM Mass Spectrometer

May 30, 2025, 7:00 AM EDT - 4 weeks ago

Bruker Launches Novel timsMetabo™ Mass Spectrometer for Breakthrough 4D-Metabolomics and 4D-Lipidomics Sensitivity, Specificity and Annotation Confidence - at Speed, Depth, and Scale

May 28, 2025, 7:00 AM EDT - 4 weeks ago

Bruker Introduces Novel MOVE-T System for Transferable, Robust Milk and Liquid Dairy Analysis with FT-NIR Technology

May 15, 2025, 7:00 AM EDT - 6 weeks ago

Bruker Announces Quarterly Dividend

May 14, 2025, 7:00 AM EDT - 6 weeks ago

Bruker and 10x Genomics Reach Global Settlement of Patent Litigation

May 7, 2025, 1:12 PM EDT - 7 weeks ago

Bruker Corporation (BRKR) Q1 2025 Earnings Call Transcript

May 7, 2025, 7:00 AM EDT - 7 weeks ago

Bruker Reports First Quarter 2025 Financial Results

Apr 25, 2025, 7:00 AM EDT - 2 months ago

Bruker Spatial Biology Pushes Boundaries in Spatial Biology and Multiomics at AACR 2025

Apr 24, 2025, 7:30 AM EDT - 2 months ago

Bruker to Launch Beacon Discovery™ at AACR 2025, Expanding Access to Live Single-Cell Functional Analysis

Apr 23, 2025, 6:15 AM EDT - 2 months ago

Solis Agrosciences Names Crystal Winkeler Chief Business Officer to Drive Commercial Growth

Apr 17, 2025, 9:00 AM EDT - 2 months ago

Bruker Introduces nVista 2P Miniature Microscope

Apr 16, 2025, 6:00 AM EDT - 2 months ago

Bruker Announces Majority Acquisition of RECIPE, a Leading Provider of Mass Spectrometry-based Diagnostic Assay Kits for Therapeutic Drug Monitoring

Apr 11, 2025, 10:17 AM EDT - 2 months ago

Why Is Life Science Focused Bruker Stock Trading Higher On Friday?

Apr 11, 2025, 8:00 AM EDT - 2 months ago

Bruker Announces First Quarter 2025 Preliminary Revenue

Apr 11, 2025, 6:00 AM EDT - 2 months ago

Bruker Complements Fast, Cost-effective IR Biotyper® Hospital Hygiene Testing and HAI Tracing with NGS Reflex Testing

Apr 7, 2025, 7:01 AM EDT - 2 months ago

Bruker Announces First-of-a-kind 1.3 GHz High-Resolution NMR System

Apr 7, 2025, 7:00 AM EDT - 2 months ago

Bruker Introduces Innovative Fourier 80 Multinuclear Benchtop FT-NMR

Apr 2, 2025, 7:00 AM EDT - 3 months ago

Bruker Announces Introduction of Revolutionary d-DNP Polarizer for MRI Research and for Dynamic Nuclear Polarization Liquids NMR

Feb 27, 2025, 10:49 AM EST - 4 months ago

Bruker Launches X4 POSEIDON™ Advanced X-Ray Microscope for Three-Dimensional Microscopy in Industrial and Scientific Applications

Feb 24, 2025, 7:00 AM EST - 4 months ago

Bruker Advances Single-Cell Proteomics and Immunopeptidomics Performance; Unveils New Proteomics Software and Applications for Enhanced Biological Insights at US HUPO

Feb 21, 2025, 8:01 AM EST - 4 months ago

Bruker Spatial Biology to Announce Groundbreaking Advances at AGBT 2025

Feb 21, 2025, 8:00 AM EST - 4 months ago

Bruker Appoints Laura Francis to its Board of Directors

SIBN

Feb 20, 2025, 4:01 PM EST - 4 months ago

Bruker Corporation to Present at Upcoming Investor Conferences

Feb 13, 2025, 3:22 PM EST - 4 months ago

Bruker Corporation (BRKR) Q4 2024 Earnings Call Transcript

Feb 13, 2025, 7:00 AM EST - 4 months ago

Bruker Reports Fourth Quarter and Full Year 2024 Financial Results

Feb 7, 2025, 7:00 AM EST - 5 months ago

Bruker Announces Date and Time of Fourth Quarter 2024 Earnings Release and Webcast

Jan 19, 2025, 5:51 PM EST - 5 months ago

Bruker Corporation Pivots To Capitalize Its Growing TAM

Jan 8, 2025, 7:00 AM EST - 6 months ago

Bruker Launches Infrared Imaging Microscope for Pharma and Life Science Research

Jan 7, 2025, 4:05 PM EST - 6 months ago

Bruker Corporation to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Dec 24, 2024, 9:28 AM EST - 6 months ago

Bruker Comments on Delaware District Court's Post-Trial Ruling in Case Involving GeoMx Digital Spatial Profiler Products

Dec 23, 2024, 4:05 PM EST - 6 months ago

U.S. District Court Awards 10x Genomics Permanent Injunction in Patent Infringement Lawsuit Against Bruker Corporation's GeoMx Products

TXG

Dec 20, 2024, 6:00 AM EST - 6 months ago

Bruker Announces 1.2 GHz NMR Spectrometer at Swiss High-field NMR Facility

Dec 2, 2024, 7:00 AM EST - 7 months ago

Bruker Introduces Dimension Nexus™ Atomic Force Microscope

Nov 8, 2024, 7:00 AM EST - 8 months ago

Bruker Announces EpicIFTM, Revolutionary Fluorescence Signal Removal Technology, Transforming CellScape Spatial Proteomics Platform

Nov 5, 2024, 11:53 AM EST - 8 months ago

Bruker Corporation (BRKR) Q3 2024 Earnings Call Transcript

Nov 5, 2024, 7:00 AM EST - 8 months ago

Bruker Reports Third Quarter 2024 Financial Results

Oct 28, 2024, 4:05 PM EDT - 8 months ago

Bruker Announces Date and Time of Third Quarter 2024 Earnings Release and Webcast

Oct 21, 2024, 6:00 AM EDT - 8 months ago

Bruker Announces One-Hundred Dollar, Deep, High-Accuracy Plasma Proteome; Advances Glycoproteomics and Metaproteomics

Oct 17, 2024, 8:58 AM EDT - 9 months ago

European Unified Patent Court Rules in Favor of Bruker and NanoString, Invalidating Patent Asserted By 10x Genomics against NanoString's CosMx SMI Products

Oct 17, 2024, 8:30 AM EDT - 9 months ago

Biognosys Presents Major Innovations Across the Spectrum of Proteomics Research Applications at the HUPO World Congress

Oct 11, 2024, 7:00 AM EDT - 9 months ago

Bruker Announces Formation of New Bruker Spatial Biology Division

Oct 7, 2024, 7:00 AM EDT - 9 months ago

Bruker Introduces Innovative Neuroscience Research Solution with High-Speed OptoVolt Voltage Imaging

Oct 2, 2024, 7:00 AM EDT - 9 months ago

Bruker Acquires Dynamic Biosensors, a Pioneer of Single-Cell Interaction Cytometry Systems for Drug Discovery

Sep 20, 2024, 9:14 AM EDT - 10 months ago

Assessment of the Dermatology Diagnostic Devices Market, 2020-2030, Featuring Strategic Analysis of Canfield Scientific, Leica Microsystems, Welch Allyn, Bruker, Heine Optotechnik & More

JarvisFlow Jun. 26 at 6:00 PM

B of A Securities updates rating for Bruker ( $BRKR ) to Buy, target set at 61 → 50.

0 · Reply

Professler Jun. 26 at 3:04 PM

$CYN Excellent trade today. Along with $BRKR . I'm locked and loaded in Bruker for the long term. With only a 6B market cap, this will double by the end of the year.

0 · Reply

DonCorleone77 Jun. 25 at 10:07 PM

0 · Reply

Roberto_Claro Jun. 25 at 9:47 PM

0 · Reply

JMG2000 Jun. 25 at 7:00 PM

$BRKR watching

0 · Reply

Professler Jun. 10 at 2:40 PM

$BRKR About time this gets some love. There's too much growth potential and excellent technology here to keep it down forever. See you at 60 soon.

0 · Reply

topstockalerts Jun. 10 at 1:55 PM

$BRKR it took off.. 🙌 Stay tuned for more!🍾🍾

0 · Reply

ZacksResearch Jun. 10 at 1:14 PM

0 · Reply

ZacksResearch Jun. 10 at 11:08 AM

0 · Reply

MVL0502 Jun. 3 at 2:48 PM

0 · Reply

DonCorleone77 Jun. 2 at 11:33 AM

$BRKR Bruker launches new timsUltra AIP system Bruker Corporation announced significant further advances in ultra-high sensitivity 4D-Proteomics with the introduction of the timsUltra AIP mass spectrometer. Its Athena Ion Processor, AIP, technology further boosts the extreme sensitivity of timsTOF Ultra PASEF methods for key biological and clinical research problems with very low sample amounts.

0 · Reply

DonCorleone77 Jun. 2 at 11:22 AM

$BRKR Bruker unveils new proteoElute nanoLC system, PepSep Advanced nLC columns At the 73rd Conference on Mass Spectrometry and Allied Topics, Bruker Corporation announced the new proteoElute nanoLC system, featuring ceramic valves, proteoTrap trapping columns, and next-generation PepSep Advanced nLC columns, further enhancing robustness, sensitivity and proteome coverage in ultra-sensitive proteomics workflows. The company introduced: a new proteoElute nanoflow nLC system features ceramic valves, proteoTrap trapping columns, and TwinScape-enabled predictive maintenance technology and a new generation of PepSep Advanced nLC columns to further improve chromatographic resolution, sensitivity and proteomics identifications

0 · Reply

DonCorleone77 May. 30 at 11:38 AM

$BRKR Bruker launches timsMetabo mass spectrometer Bruker Corporation launched timsMetabo, a 4D-Metabolomics mass spectrometer delivering sensitivity, separation power and annotation confidence for small molecules, further enhanced by the novel TIMS 'MoRE' scan-mode. The timsMetabo system enables the generation of a 'digital metabolome archive' for every sample, providing TIMS-enabled qual-quant performance with greatly increased confidence for automated annotation, leveraging 4D separations and reproducible molecular collision cross sections at scale for 4D-Metabolomics and 4D-Lipidomics.

0 · Reply

ZacksResearch May. 29 at 4:06 PM

$BRKR unveils the MOVE-T analyzer to boost quality and efficiency in the dairy industry, setting new standards for precision and reliability. Discover more: https://www.zacks.com/stock/news/2478731/bruker-stock-to-gain-from-the-launch-of-move-t-liquid-dairy-analyzer?cid=sm-stocktwits-2-2478731-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2478731_TEASER

0 · Reply

ZacksResearch May. 29 at 1:12 PM

$BRKR launches MOVE-T — an innovative solution for dairy quality control! 🥛 The new liquid dairy analyzer uses advanced FT-NIR technology for precise and reliable results, setting a new benchmark in the industry. Despite a recent stock dip, this innovation could boost market sentiment for BRKR. Discover the full potential here 👉 https://www.zacks.com/commentary/2478731/bruker-stock-to-gain-from-the-launch-of-move-t-liquid-dairy-analyzer?cid=sm-stocktwits-2-2478731-body&ADID=SYND_STOCKTWITS_TWEET_2_2478731_BODY

0 · Reply

JarvisFlow May. 22 at 12:00 PM

Citigroup has adjusted their stance on Bruker ( $BRKR ), setting the rating to Neutral with a target price of 50 → 40.

0 · Reply

Jodah May. 21 at 7:11 PM

$BRKR If you’re looking for a downhill ride, try investing in Bruker stock

0 · Reply

Moneymancrypto May. 14 at 6:07 PM

$BRKR Deal $NVDA $AAPL $HIMS $HOLO

0 · Reply

Moneymancrypto May. 14 at 6:07 PM

$BRKR Good price here

0 · Reply

50bps May. 14 at 1:01 PM

$BRKR lost track of this one. what a train wreck

0 · Reply

DonCorleone77 May. 14 at 11:10 AM

$BRKR $TXG Bruker, 10x Genomics reach final settlement to resolve patent disputes Bruker (BRKR) announced that Bruker and 10x Genomics (TXG) have reached a final settlement to resolve their patent disputes and dismiss multiple litigations, with global patent cross license agreements between the two companies. In connection with the settlement, all ongoing lawsuits and administrative proceedings filed by both companies in several countries, including actions pending in the United States, in Germany, and before the European Unified Patent Court, will be withdrawn.

0 · Reply

NorthShoreTrader2021 May. 13 at 9:34 PM

$BRKR AbCellera Biologics announced that the United States Court of Appeals for the Federal Circuit affirmed the validity of its U.S. Patent No. 10,087,408, which pertains to microfluidic devices used for culturing and selectively recovering cells. This decision follows a challenge by Bruker Cellular Analysis, Inc., which was rejected by the U.S. Patent Trial and Appeal Board and now confirmed by the Federal Circuit. This ruling strengthens AbCellera’s intellectual property portfolio and supports its ongoing patent infringement litigation against Bruker in the U.S. District Court for the Northern District of California.

0 · Reply

Market Cap	6.39B
Revenue (ttm)	3.37B
Net Income (ttm)	113.10M
EPS (ttm)	N/A
PE Ratio	17.42
Forward PE	16.71
Profit Margin	3.36%
Debt to Equity Ratio	1.15

Volume	5,247,900
Avg Vol	2,390,198
Day's Range	N/A - N/A
Shares Out	151.53M
Stochastic %K	81%
Beta	1.16
Analysts	Sell
Price Target	$54.75